9/11 flu warning
22 October 2002 8:14 GMT
by Julie Clayton
Malta - The chaos that surrounded the anthrax outbreak
following the events of September 11 last year was minor compared
with what could happen when a major flu pandemic occurs, says
epidemiologist Kathleen Gensheimer. Taking note, US authorities
are applying lessons learned from 9/11 to prepare for the
potentially catastrophic consequences of the next flu pandemic.
Gensheimer, state epidemiologist at the main department of
human services in Augusta, Maine, and member of the US National
Influenza Pandemic Steering Committee, today reported a billion
dollar injection of cash across the US to deal with public health
issues. Public health is enjoying a renaissance in the States,
Gensheimer told delegates at the
First European Influenza Conference here, and is giving the
real threat of a flu pandemic the attention it deserves.
"The worst bioterrorist may be nature itself," she told a
symposium on Pandemic Planning and Preparedness. "We always have
to be prepared for the unexpected."
Gensheimer emphasized that, in contrast to the uncertainty over
whether or not bioterrorists may strike again, a major flu
pandemic is a certainty - the only question is when.
The prospect of a bioengineered version of influenza as a new
bioterrorist weapon was more debatable, she said, than the
likelihood of a natural catastrophic influenza outbreak.
The worst pandemic last century was the "Spanish flu," which
killed more than 50 million people around the world between 1917
and 1919. Then came the 1957 and 1968 epidemics, which between
them accounted for another 40 million deaths. With a periodic
repeat pattern of approximately 30 years, researchers predict that
we are now due for another pandemic.
Influenza pandemics and bioterrorist attacks have much in
common when it comes to the action required for protecting people
against infection, and preventing deaths in those that become
infected. But last year, many of these elements were missing, or
inadequate, when anthrax was sent through the US postal system,
killing five people, says Gensheimer.
She summarized the situation as "miscalculation, missteps, and
misunderstanding." She highlighted, in particular, the absence of
a central command control to decide how to assess and deal with
the anthrax outbreak, as well as the lack of communication between
different agencies involved. As a result, there was too much
uncertainty over who was at risk, and therefore who should receive
prophylactic antibiotics, as well as ignorance about the necessary
duration of treatment. A decision to investigate vaccine
availability was only made at a very late stage, she notes.
Many new developments are now taking place in the US as a
result of the analysis of what went wrong last year. One is an
increase in surge capacity at public health laboratories, so as to
cope with a potentially massive rise in specimens. In addition,
there are efforts to develop year-round detection and tracking of
novel viral variants as they emerge during normal winter flu
epidemics.
The authorities are also "trying hard" to expand vaccination
coverage, on the grounds that, with a sufficiently large
infrastructure in place, it will be easier to meet demand in the
event of a pandemic.
Delegates at the symposium also heard that northern neighbor
Ontario, Canada, is already leading the way, with regard to
vaccination coverage. Ontario has the world's most advanced
universal vaccination program, which offers free flu jabs to all
11 million inhabitants. The latest figure shows that around 44% of
the population accepted the offer during the 2001/2002 season,
according to Monali Varia, epidemiologist and program coordinator
for the Universal Influenza Immunization Program, Ontario Ministry
of Health and Long-Term Care.
Picture caption and credit:
Left, photomicrograph of Haemophilus influenzae, and right,
Bacillus anthracis from agar culture, CDC.

|
Send us your
comments for
publication.
|
| Sign up for BioMedNet News weekly
email alerts. |